| scholarly article | Q13442814 |
| P50 | author | Seyed Moayed Alavian | Q28321890 |
| P2093 | author name string | Michael Roggendorf | |
| Mahmood Mahmoodi | |||
| Reza Malekzadeh | |||
| Hossein Keyvani | |||
| Zahra Goodarzi | |||
| Seyed Mohammad Jazayeri | |||
| Ghodratollah Montazeri | |||
| Hadi Karimzadeh | |||
| Shahram Mirmomen | |||
| Maryam Daram | |||
| P2860 | cites work | Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients. | Q31912504 |
| New antiviral agents for the therapy of chronic hepatitis B virus infection | Q33749351 | ||
| Immunogenicity of recombinant hepatitis B virus vaccine in patients with and without chronic hepatitis C virus infection: a case-control study | Q33787868 | ||
| Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B | Q33883607 | ||
| Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen | Q34269133 | ||
| Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. | Q34470578 | ||
| Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals | Q35360487 | ||
| Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant | Q35614036 | ||
| Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection | Q35763331 | ||
| Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen | Q36632713 | ||
| Vaccines and immunotherapies against hepatitis B and hepatitis C viruses | Q36980759 | ||
| Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis | Q40975136 | ||
| Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants | Q41654439 | ||
| Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes | Q41666814 | ||
| Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus | Q42673914 | ||
| Hepatitis B virus (HBV) vaccine-induced escape mutants of HBV S gene among children from Qidong area, China | Q43479073 | ||
| Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. | Q43563104 | ||
| Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. | Q44583424 | ||
| Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease | Q44914689 | ||
| Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission | Q45183116 | ||
| Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically | Q45480498 | ||
| Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern | Q45645708 | ||
| Immune therapy of hepatitis B virus chronic infection | Q45744179 | ||
| Hepatitis B virus genotypic resistance to lamivudine | Q45746066 | ||
| Hepatitis B virus (HBV)-specific in vitro antibody production by peripheral blood mononuclear cells (PBMC) after vaccination by recombinant hepatitis B surface antigen (rHBsAg). | Q45772020 | ||
| Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. | Q45850067 | ||
| Vaccine-induced escape mutant of hepatitis B virus | Q45860147 | ||
| HBV core sequence: definition of genotype-specific variability and correlation with geographical origin | Q48166961 | ||
| Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan | Q58621162 | ||
| Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine | Q58802861 | ||
| Specific vaccine therapy in chronic hepatitis B infection | Q62658380 | ||
| Vaccination against hepatitis B: results of the analysis of 2000 population members in Croatia | Q72554700 | ||
| Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides | Q72584538 | ||
| Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants | Q77643503 | ||
| Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma | Q78202690 | ||
| Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease | Q80243377 | ||
| The effect of recombinant hepatitis B vaccine therapy in chronic hepatitis B infection | Q82084376 | ||
| P433 | issue | 9 | |
| P921 | main subject | Hepatitis B vaccine | Q117749 |
| chronic hepatitis B | Q55779876 | ||
| P304 | page(s) | 638-645 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Iranian Journal of Basic Medical Sciences | Q20850646 |
| P1476 | title | Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy | |
| P478 | volume | 17 |
| Q28076279 | Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection | cites work | P2860 |
Search more.